Perrigo Down 11.1% Since SmarTrend Downtrend Call (PRGO)
Comtex SmarTrend(R) - Mon Apr 14, 10:04AM CDT
SmarTrend identified a Downtrend for Perrigo (NASDAQ
SmarTrend Watching for Potential Rebound in Shares of Perrigo After 3.72% Loss
Comtex SmarTrend(R) - Thu Apr 10, 4:29PM CDT
Perrigo (NASDAQ
Perrigo Company (PRGO) Showing Signs Of Being A Roof Leaker
at The Street - Thu Apr 10, 12:43PM CDT
Trade-Ideas LLC identified Perrigo Company (PRGO) as a "roof leaker" (crossing below the 200-day simple moving average on higher than normal relative volume) candidate
Can Perrigo Company PLC Continue Its Bull Run?
Stephen D., Simpson,, The Motley Fool - Motley Fool - Wed Apr 09, 1:30PM CDT
There's a pretty good chance that if you use store-brand OTC consumer health products, you have a Perrigo product in your bathroom right now. Perrigo hasn't completely eschewed the prescription-based generic drug business that build companies like...
Canadian Pet Market Outlook, 2014 Featuring Bayer, Hill's, Perrigo, Purina, VCA Antech & Walmart
M2 - Tue Apr 08, 8:57AM CDT
Research and Markets (http://www.researchandmarkets.com/research/64pj3p/canadian_pet) has announced the addition of the "Canadian Pet Market Outlook, 2014" report to their offering. The proprietary survey of Canadian pet owners shows that the vast majority of pet owners are willing to spend more on products that support the health and happiness of their pets. This trend is borne out in the sales data. Canadian pet market sales have grown at a slow but steady pace over the past five years, hovering at a 4% rate, quite a feat for such a large, mature market. Another trend continuing to gain steam is the market emphasis on natural products, a thrust illustrated by M&A activity and the entry of industry heavy hitters into this market sphere, with companies ranging from Purina to Hill's Science Diet to Walmart focusing on natural products. Pet health has proven to be a particularly attractive segment as well. As the Canadian pet population has aged, the market investment of big players such as Bayer and Perrigo has increased. The Canadian pet healthcare industry was particularly impacted by VCA Antech's 2012 acquisition of Canada's largest animal hospital chain, Associate Veterinary Clinics. Combining extensive monitoring of the pet market with an exclusive pet owner survey, Canadian Pet Market Outlook, 2014 is the go-to source for a complete understanding of the Canadian pet industry. In its first Canadian edition, the report evaluates current trends and future directions for marketing and retailing, along with consumer patterns across the full spectrum of the market, including veterinary services, pet food, nonfood pet supplies, and non-medical pet services (grooming, boarding, training, etc.). Key Topics Covered: Chapter 1: Executive Summary Chapter 2: Highlights/Market Trends Chapter 3: Highlights/Industry Trends Chapter 4: Highlights/ Retail Trends Chapter 5: Highlights/ Pet Ownership Trends Companies Mentioned - Bayer - Hill's - Perrigo - Purina - VCA Antech - Walmart For more information visit http://www.researchandmarkets.com/research/64...nadian_pet
Divestitures, New Drug Launches, Product Deliveries, Latest News and Stock Updates - Analyst Notes on Encana, Perrigo, Boeing, Genworth, and Itau Unibanco
PR Newswire - Tue Apr 08, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Encana Corporation (NYSE: ECA), Perrigo Company PLC (NYSE: PRGO), The Boeing Company (NYSE: BA), Genworth Financial Inc. (NYSE: GNW), and Itau Unibanco Holding SA (NYSE: ITUB). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pivotal Study Positive Results, Appointments, Proposed Public Offerings, Financial Results, and Product Launches - Analyst Notes on Amgen, Humana, Aetna, Perrigo, and Charles River
PR Newswire - Mon Apr 07, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Amgen Inc. (NASDAQ: AMGN),
Mylan to Buy Swedish Company? - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Fri Apr 04, 10:30AM CDT
According to a report in the Financial Times, Mylan is looking to acquire Meda AB.
Perrigo announces first shipment of approved generic Taclonex Ointment for the topical treatment of plaque psoriasis
M2 - Wed Apr 02, 5:03AM CDT
Health care company Perrigo Company (NYSE
Perrigo Announces Launch Of Authorized Generic Version Of Taclonex® Ointment (Calcipotriene 0.005% / Betamethasone Dipropionate 0.064%)
PR Newswire - Tue Apr 01, 7:16AM CDT
Perrigo Company plc (NYSE: PRGO; TASE) today announced that it has initiated market launch and made its first shipments of the authorized generic version of LEO Pharma A/S' Taclonex® Ointment (calcipotriene 0.005% / betamethasone dipropionate 0.064%).
Biotechs Giving Uncle Sam the Shaft
Brian Orelli, The Motley Fool - Motley Fool - Mon Mar 31, 5:08PM CDT
As they say in real estate: location, location, location. Biotechs have been acquiring companies in large part for their address. Specifically, they're buying so they can move to places like Ireland, where taxes are substantially lower than in the...
Perrigo Inks Deal - Analyst Blog
Zacks Equity Research - Zacks Investment Research - Thu Mar 27, 5:30PM CDT
Perrigo inked a deal to manufacture store brand versions of nutritional drinks for adults.
Perrigo and KanPak partnership to manufacture store brand Ensure versions of adult nutritional drinks
M2 - Thu Mar 27, 6:31AM CDT
Healthcare company Perrigo Company (NYSE
Perrigo Partners With Division Of Golden State Foods To Manufacture Store Brand Versions Of Ensure® Adult Nutritional Drinks
PR Newswire - Wed Mar 26, 8:40AM CDT
Perrigo Company plc (NYSE: PRGO; TASE) today announced that its Nutritionals segment is partnering with KanPak LLC to manufacture store brand adult nutritional drinks comparable to Ensure® products. KanPak is a leading supplier of beverages and desserts using aseptic processing technology. In 2013 Golden State Foods (GSF), one of the largest diversified food processors and distributors in the United States, acquired a controlling interest in KanPak. Perrigo will supply retailers with six store brand versions of the six nutritional drinks currently sold in the Ensure® line. The adult nutritional drink market represents $900 million in annual branded sales for the last 12 months, as measured by SymphonyIRI Group.
Extended and New Partnerships, and Upcoming Conferences - Analyst Notes on Perrigo, Intuitive Surgical, Aetna, St Jude Medical, and Stryker
PR Newswire - Wed Mar 26, 7:00AM CDT
Today, Analysts Review released its analysts' notes regarding Perrigo Company (NYSE: PRGO), Intuitive Surgical, Inc. (NASDAQ: ISRG), Aetna Inc. (NYSE: AET), St. Jude Medical, Inc. (NYSE: STJ), and Stryker Corporation (NYSE: SYK). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.AnalystsReview.com/register
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Zacks Analyst Interviews
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Arpita Dutt - Zacks Investment Research - Wed Mar 26, 1:17AM CDT
Pharma & Biotech Stock Outlook - March 2014 - Industry Outlook
Cramer: Embrace 'The New Frugality' and These Stocks
at The Street - Tue Mar 25, 3:20PM CDT
TheStreet's Jim Cramer encourages investors to embrace "the new frugality" and suggests several stocks that reflect this theme. Firstly, Cramer points out "people just aren't spending the way that they used to" in the wake of the Great Recession....
3 Warning Signs the Biotech Rally May Be Over
Sean Williams, The Motley Fool - Motley Fool - Tue Mar 25, 11:10AM CDT
Yes, despite contrary belief, biotech stocks can actually go down just as they've been going up, and up, and up some more over the past couple of years. Friday's tumble in the SPDR S&P Biotech ETF on the heels of congressional probing into...